Evidence map›Paper›PMID 28598324›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2017

A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016.

Juan Bellido-Blasco, Silvia Guiral-Rodrigo, Ana Míguez-Santiyán, Antonio Salazar-Cifre, Francisco González-Morán

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Improving Tdap maternal immunization rate in Saudi Arabia.Human vaccines & immunotherapeutics · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Juan Bellido-BlascoEpidemiology Department. Public Health Centre of Castelló (DGSP), Castelló, Spain.
Silvia Guiral-RodrigoSurveillance and Epidemiologic Control Unit, Public Health Directorate, Regional Government of Valencia, Spain.
Ana Míguez-SantiyánEpidemiology Department. Public Health Centre of València (DGSP), València, Spain.
Antonio Salazar-CifreEpidemiology Department. Public Health Centre of València (DGSP), València, Spain.
Francisco González-MoránSurveillance and Epidemiologic Control Unit, Public Health Directorate, Regional Government of Valencia, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Valencian Community (Spain), the programme of maternal pertussis vaccination during pregnancy started in January 2015. The objective of this study was to estimate in this region the vaccine effectiveness (VE) in protecting newborns against laboratory-confirmed pertussis infection. A matched case-control study was undertaken in the period between 1 March 2015 and 29 February 2016. Twenty-two cases and 66 controls (+/- 15 days of age difference) were included in the study. Cases were non-vaccinated infants < 3 months of age at disease onset testing positive for pertussis by real-time PCR. For every case three unvaccinated controls were selected. Odds ratios (OR) were calculated by multiple conditional logistic regression for association between maternal vaccination and infant pertussis. Other children in the household, as well as mother- and environmental covariates were taken into account. The VE was calculated as 1 - OR. Mothers of five cases (23%) and of 41 controls (62%) were vaccinated during pregnancy. The adjusted VE was 90.9% (95% confidence interval (CI): 56.6 to 98.1). The only covariate in the final model was breastfeeding (protective effect). Our study provides evidence in favour of pertussis vaccination programmes for pregnant women in order to prevent whooping cough in infants aged less than 3 months.

Indexed as

VaccinationAntibodies, BacterialBordetella pertussisCase-Control StudiesFemaleHumansImmunization ScheduleInfant, NewbornInfectious Disease Transmission, VerticalMalePertussis VaccinePregnancyPregnancy Complications, InfectiousReal-Time Polymerase Chain ReactionSpainWhooping CoughAntibodies, BacterialPertussis VaccineMatched case–control studyPertussis and gestationPertussis immunizationPertussis newborn protection

Identifiers

PMID28598324
PMCPMC5479988
OpenAlexW2624177571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.